ClinicalTrialsFinder

Recurrent Infection Clinical Trials in Clermont-Ferrand

1 recruitingClermont-Ferrand, France

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients

Clostridioides Difficile InfectionRecurrent Infection
Hospices Civils de Lyon56 enrolled9 locationsNCT06306014